Drug Type Small molecule drug |
Synonyms BCWP_C003, JLP 1310 |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H28CaFN3O6S |
InChIKeyAVDMILNVMOXCHF-DHMAKVBVSA-N |
CAS Registry147098-20-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 1 | KR | 06 Jul 2017 | |
Hyperlipidemias | Phase 1 | KR | 06 Jul 2017 |